Romania IVD Market, by Product (REAGENTS, INSTRUMENTS, SOFTWARE AND SERVICES), by Technique (IMMUNODIAGNOSTICS, HEMATOLOGY, MOLECULAR DIAGNOSTICS, TISSUE DIAGNOSTICS, CLINICAL CHEMISTRY, Others), by Application (CANCER, INFECTIOUS DISEASES, CARDIAC DISEASES, IMMUNE SYSTEM DISORDERS, NEPHROLOGICAL DISEASES, GASTROINTESTINAL DISEASES, Others) and, by End User (STANDALONE LABORATORIES, HOSPITALS CLINICS, ACADEMIC AND RESEARCH INSTITUTIONS, POINT OF CARE TESTING, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

• REAGENTS
• INSTRUMENTS
• SOFTWARE AND SERVICES

• IMMUNODIAGNOSTICS
• HEMATOLOGY
• MOLECULAR DIAGNOSTICS
• TISSUE DIAGNOSTICS
• CLINICAL CHEMISTRY
• Others

• CANCER
• INFECTIOUS DISEASES
• CARDIAC DISEASES
• IMMUNE SYSTEM DISORDERS
• NEPHROLOGICAL DISEASES
• GASTROINTESTINAL DISEASES
• Others

• STANDALONE LABORATORIES
• HOSPITALS & CLINICS
• ACADEMIC AND RESEARCH INSTITUTIONS
• POINT OF CARE TESTING
• Others

Abbott Laboratories, QIAGEN N.V., Sysmex Corporation, F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter Inc.), Siemens AG, bioMérieux SA, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc.